Aethlon Medical - AEMD Stock Price Target and Predictions

  • Consensus Rating: N/A
  • Consensus Price Target: $4.00
  • Forecasted Upside: 517.28 %
  • Number of Analysts: 0
  • Breakdown:
  • 0 Sell Ratings
  • 0 Hold Ratings
  • 0 Buy Ratings
  • 0 Strong Buy Ratings
$0.65
▼ -0.03 (-4.42%)

This chart shows the closing price for AEMD by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New Aethlon Medical Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for AEMD and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for AEMD

Analyst Price Target is $4.00
▲ +517.28% Upside Potential
This price target is based on 0 analysts offering 12 month price targets for Aethlon Medical in the last 3 months. The average price target is $4.00, with a high forecast of $4.00 and a low forecast of $4.00. The average price target represents a 517.28% upside from the last price of $0.65.

This chart shows the closing price for AEMD for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart

Current Consensus is N/A

The current consensus among 0 polled investment analysts is to n/a stock in Aethlon Medical. This rating has held steady since July 2022, when it changed from a Buy consensus rating.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
4/4/2021
  • 0 strong buy ratings
  • 2 buy ratings
  • 0 hold ratings
  • 0 sell ratings
7/3/2021
  • 0 strong buy ratings
  • 2 buy ratings
  • 0 hold ratings
  • 0 sell ratings
10/1/2021
  • 0 strong buy ratings
  • 2 buy ratings
  • 0 hold ratings
  • 0 sell ratings
12/30/2021
  • 0 strong buy ratings
  • 2 buy ratings
  • 0 hold ratings
  • 0 sell ratings
3/30/2022
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
6/28/2022
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
8/27/2022
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
9/26/2022

Latest Recommendations

  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
2/15/2022Maxim GroupLower Target$11.00 ➝ $4.00High
8/10/2021HC WainwrightReiterated RatingBuy$9.00Medium
6/25/2021Maxim GroupReiterated RatingBuy$11.00Low
6/25/2021HC WainwrightBoost TargetBuy$5.00 ➝ $9.00Low
6/15/2021Maxim GroupBoost TargetBuy$6.00 ➝ $11.00Low
6/1/2021HC WainwrightInitiated CoverageBuy$5.00High
1/8/2021Maxim GroupInitiated CoverageBuy$6.00Medium
11/8/2018HC WainwrightSet TargetBuy$3.00Medium
8/9/2018HC WainwrightSet TargetBuy$3.00High
6/11/2018HC WainwrightSet TargetBuy$3.00High
11/20/2017HC WainwrightInitiated CoverageBuy ➝ Buy$3.00N/A
(Data available from 9/26/2017 forward)

News Sentiment Rating

-0.05 (Hold)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 1 very positive mentions
  • 2 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
2/28/2022
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
3/30/2022
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
4/29/2022
  • 3 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
5/29/2022
  • 0 very positive mentions
  • 1 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
6/28/2022
  • 0 very positive mentions
  • 4 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
7/28/2022
  • 0 very positive mentions
  • 4 positive mentions
  • 2 negative mentions
  • 0 very negative mentions
8/27/2022
  • 0 very positive mentions
  • 2 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
9/26/2022

Current Sentiment

  • 0 very positive mentions
  • 2 positive mentions
  • 1 negative mentions
  • 0 very negative mentions

Recent Stories by Sentiment

Very Negative

  • No very negative mentions tracked during this time.

Positive

Very Positive

  • No very positive mentions tracked during this time.
Aethlon Medical logo
Aethlon Medical, Inc., a medical technology company, focuses on developing products to diagnose and treat life and organ threatening diseases in the United States. The company develops Aethlon Hemopurifier, a clinical-stage immunotherapeutic device that removes tumor-derived exosomes and life-threatening viruses from the human circulatory system, including removal of COVID-19 virus, associated variants, and related exosomes. Aethlon Medical, Inc. has a collaboration with the University of Pittsburgh Medical Center Hillman Cancer Center for studies related to head and neck cancer. The company was founded in 1999 and is based in San Diego, California.
Read More

Today's Range

Now: $0.65
Low: $0.62
High: $0.69

50 Day Range

MA: $1.14
Low: $0.68
High: $1.99

52 Week Range

Now: $0.65
Low: $0.62
High: $4.58

Volume

255,156 shs

Average Volume

1,645,361 shs

Market Capitalization

$10.78 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.75

Frequently Asked Questions

What sell-side analysts currently cover shares of Aethlon Medical?

The following Wall Street research analysts have issued research reports on Aethlon Medical in the last year: Maxim Group, and StockNews.com.
View the latest analyst ratings for AEMD.

What is the current price target for Aethlon Medical?

1 Wall Street analysts have set twelve-month price targets for Aethlon Medical in the last year. Their average twelve-month price target is $4.00, suggesting a possible upside of 517.3%. Maxim Group has the highest price target set, predicting AEMD will reach $4.00 in the next twelve months. Maxim Group has the lowest price target set, forecasting a price of $4.00 for Aethlon Medical in the next year.
View the latest price targets for AEMD.

What is the current consensus analyst rating for Aethlon Medical?

Aethlon Medical currently has from Wall Street analysts. The stock has a consensus analyst rating of "N/A."
View the latest ratings for AEMD.

What other companies compete with Aethlon Medical?

How do I contact Aethlon Medical's investor relations team?

Aethlon Medical's physical mailing address is 9635 GRANITE RIDGE DRIVE SUITE 100, SAN DIEGO CA, 92123. The medical equipment provider's listed phone number is (858) 459-7800 and its investor relations email address is [email protected] The official website for Aethlon Medical is www.aethlonmedical.com. Learn More about contacing Aethlon Medical investor relations.